GlassScriptPhysician profile
Ali H Sheikh
NPI 1013148048
$13,977.68
in general payments reported to CMS, 2019-2025
25 companies · $3,307 in 2025
The $3,307 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,643 · 2020: $645 · 2021: $989 · 2022: $939 · 2023: $3,750 · 2024: $1,703 · 2025: $3,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,445 · Food and Beverage: $3,215 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,445.05 |
| Food and Beverage | $3,215.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,974.00 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Cobalt Dr Mri Surescan |
| Medtronic Vascular, INC. | $2,397.65 | 2019-2020 | |
| Biosense Webster, INC. | $1,062.27 | 2021-2025 | Carto 3 |
| Abbott Laboratories | $899.59 | 2019-2025 | Ensite, Ensite Precision, Aveir |
| Boston Scientific Corporation | $726.52 | 2019-2024 | Watchman Access System, Watchman Flx |
| Medical Device Business Services, INC. | $540.30 | 2021 | |
| Acutus Medical, INC. | $282.35 | 2020-2023 | |
| Biotronik INC. | $222.55 | 2021-2025 | Acticor 7 Vr-T Dx |
| Atricure, INC. | $194.97 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $147.39 | 2022-2025 | Camzyos, Eliquis |
| Angiodynamics, INC. | $141.66 | 2022 | |
| Impulse Dynamics (USA) INC. | $72.93 | 2022-2025 | Optimizer |
| Janssen Pharmaceuticals, INC | $52.16 | 2021-2024 | Xarelto |
| Cardiva Medical, INC. | $44.30 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $38.13 | 2023 | Andexxa, Brilinta |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $37.63 | 2023-2025 | |
| Lundbeck LLC | $23.02 | 2019 | |
| Edwards Lifesciences Corporation | $22.91 | 2024 | Sapien 3 Ultra Resilia |
| Bridgebio Pharma, INC. | $22.18 | 2025 | Attruby |
| Novartis Pharmaceuticals Corporation | $17.34 | 2021 | |
| Amgen INC. | $16.69 | 2023 | Repatha |
| Amarin Pharma, INC. | $14.76 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.55 | 2023 | |
| Irhythm Technologies, INC. | $11.83 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Sheikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.